tldrdailynews.com logo
Tag

Randd

All articles tagged with #randd

Leaks reveal OpenAI burning billions despite revenue surge
business1 month ago

Leaks reveal OpenAI burning billions despite revenue surge

Leaked audited filings show OpenAI’s revenue rising from $3.7B in 2024 to $13.07B in 2025, with nearly $2B per month by year‑end, but R&D costs jumped to $19.18B and operating losses to $20.92B in 2025. The headline net loss hit about $39B in 2025 largely due to a ~$30B nonrecurring accounting charge tied to its shift to for‑profit status; excluding that charge, the loss would be ~ $8B. To reach profitability by 2030, the company must rein in costs (notably model training) and contend with pricing pressure from rivals, even as it boasts ~900M weekly users and a $852B valuation after a $122B financing round.

via Ars Technica|
#ai#business#finance
OpenAI’s 2025 costs surge to $34bn as IPO approaches
business1 month ago

OpenAI’s 2025 costs surge to $34bn as IPO approaches

Audited 2025 figures show OpenAI spent about $34bn overall—roughly $19bn on R&D and nearly $6bn on sales and marketing—while generating about $13bn in revenue and reaching $2bn in monthly revenue by year-end. Net losses climbed to about $39bn, driven largely by a $30bn non-cash charge tied to its pre-IPO structure; stripping non-cash items, losses were about $8bn. With $122bn raised at a $730bn valuation and an IPO planned that could exceed $1tn, OpenAI is accelerating expensive bets on models, data centers, and talent as it competes to lead the AI boom.

via Financial Times|
#artificial-intelligence#business#data-centers
Unilever Bets on Downtown New Haven with 300-Job Global Innovation Center
business1 month ago

Unilever Bets on Downtown New Haven with 300-Job Global Innovation Center

Unilever will invest $270 million to open a 200,000-square-foot Global Innovation Center in the planned 2 Church Street lab-office building in downtown New Haven, creating about 300 jobs for scientists, engineers, and researchers in skincare, personal care, fragrances, packaging, and wellbeing testing. Construction could start next year and take about 24 months, with occupancy expected in spring 2029; Quantum CT will also lease space in the same building.

via New Haven Independent|
#2-church-st#business#global-innovation-center
Unilever Plans US Innovation Hub in New Haven to Accelerate R&D
business1 month ago

Unilever Plans US Innovation Hub in New Haven to Accelerate R&D

Unilever unveiled plans for a $270 million global innovation centre in New Haven, CT, including $50 million in capex, with around 300 staff and a spring 2029 launch. The facility will consolidate skincare, hair, fragrance, packaging, and human performance testing under one roof, leveraging AI, neuroscience and university partnerships to speed product development and scale US innovations globally for beauty, wellbeing and personal care.

via Unilever|
#ai#business#innovation-centre
Navigating Tesla's R&D Strategy Amid Stock Volatility
finance2 years ago

Navigating Tesla's R&D Strategy Amid Stock Volatility

Tesla, along with Apple and Alphabet, has seen a decline in stock performance this year, prompting discussions on whether it presents a buying opportunity. Canaccord Genuity LLC Managing Director George Gianarikas suggests that for Tesla to improve its stock performance, it needs to ramp up its next generation vehicle, increase margins through full self-driving penetration leveraging AI, and continue growth in its energy storage business. Despite recent challenges, he believes that Tesla's stock has overcorrected to the downside and presents a potential buying opportunity, with a price target in the 230s based on increased volumes and improved margins in the future.

via Yahoo Finance|
#finance#investment#randd
"Bavarian Nordic Shifts Focus to Infectious Diseases, Abandons Cancer Vaccine Development"
health-and-medicine2 years ago

"Bavarian Nordic Shifts Focus to Infectious Diseases, Abandons Cancer Vaccine Development"

Bavarian Nordic has decided to shift its focus from immuno-oncology vaccine development to infectious disease research and development, discontinuing its Phase I cancer vaccine program in favor of concentrating on its mpox vaccine Jynneos, which is expected to contribute to the company's strong 2023 sales. The Danish biotech's TAEK-VAC, a cancer vaccine targeting a tumor-associated antigen, was being studied in patients with chordoma or HER2-positive breast cancer.

via Endpoints News|
#bavarian-nordic#cancer-vaccine#health-and-medicine
"The U.S. Space Access at Risk: Eating its Seed Corn"
space-technology2 years ago

"The U.S. Space Access at Risk: Eating its Seed Corn"

With the U.S. increasingly relying on SpaceX for space launches, there's a concern that rocket research and development efforts have been deprioritized by the Space Force, Air Force, and NASA. The success of SpaceX has led to a default situation where these agencies procure space launch as a service, potentially hindering independent space access. The authors argue that continued investment in rocket science and technology is crucial for future challenges, drawing parallels to historical examples of incremental research leading to significant advancements in military capabilities.

via SpaceNews|
#randd#rocket-research#space-access
Jay Bradner appointed as Amgen's R&D leader, David Reese becomes chief technology officer
business2 years ago

Jay Bradner appointed as Amgen's R&D leader, David Reese becomes chief technology officer

Amgen has appointed former Novartis research executive Jay Bradner to a top role in its research leadership, while shifting current R&D chief David Reese to lead technology and AI. Bradner previously served as head of Novartis' research arm, the Novartis Institutes for Biomedical Research, before being succeeded by Fiona Marshall. After leaving Novartis, Bradner worked as a clinician at the Dana-Farber Cancer Institute and Brigham & Women's Hospital.

via Endpoints News|
#amgen#business#david-reese
"SpaceX Starship's Explosive Test Flight: Insights and Images"
space-exploration2 years ago

"SpaceX Starship's Explosive Test Flight: Insights and Images"

SpaceX's Starship test flights are a spectacle, capturing the public's attention and excitement, but they also invite criticism. While there have been successes in terms of engine performance and safety measures, Starship has yet to complete its test missions successfully. The timelines for missions to the moon or Mars remain aspirational, as the technology is still in the research and development stage. SpaceX faces challenges from government regulators and the need for more successful flights before flying people. In other space news, the US and China dominate rocket launches, the White House supports SpaceX innovation despite recent comments by Elon Musk, and China showcases its Tiangong space station.

via CNBC|
#nasa#randd#rocket-launches